PYLCLARI

This brand name is authorized in France, Croatia, Ireland, Italy, Lithuania

Active ingredients

The drug PYLCLARI contains one active pharmaceutical ingredient (API):

1 Piflufolastat ¹⁸F UNII 3934EF02T7 - PIFLUFOLASTAT F-18

Piflufolastat (18F) is a selective secondgeneration fluorine-18-labeled small-molecule PSMA inhibitor. Based on the intensity of the signals, PET images obtained using piflufolastat (18F) indicate the presence of PSMA expressing tissues. Read about Piflufolastat ¹⁸F

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PYLCLARI Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V09IX16		V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IX Other diagnostic radiopharmaceuticals for tumour detection
Discover more medicines within V09IX16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 63404771, 68920959
Country: IT	Agenzia del Farmaco	Identifier(s): 050776018, 050776020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1097413, 1097414